Physician profile
Daniel Han
NPI 1831138049
$5,435.43
in general payments reported to CMS, 2019-2025
28 companies · $859 in 2025
The $859 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $190 · 2021: $632 · 2022: $783 · 2023: $924 · 2024: $940 · 2025: $859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,620 · Education: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,620.09 |
| Education | $102.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,111.49 | 2019-2025 | |
| Janssen Biotech, INC. | $975.03 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $742.23 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $615.95 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $330.44 | 2019-2025 | |
| Antares Pharma, INC. | $288.61 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Myovant Sciences INC. | $192.94 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $180.25 | 2019-2023 | Provenge |
| Ferring Pharmaceuticals INC. | $133.92 | 2019 | |
| Verity Pharmaceuticals INC. | $117.50 | 2024-2025 | Tlando, Trelstar |
| Bolton Medical INC | $102.05 | 2019 | |
| Procept Biorobotics Corporation | $81.89 | 2019-2024 | Aquabeam System |
| Boston Scientific Corporation | $71.55 | 2019-2023 | Rezum Generator |
| Tolmar, INC. | $64.74 | 2024-2025 | Jatenzo, Eligard |
| Merck Sharp & Dohme LLC | $52.99 | 2023 | Keytruda, Welireg, Lynparza |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $50.08 | 2022 | |
| Coloplast Corp | $48.54 | 2019-2020 | |
| Teleflex LLC | $48.22 | 2022 | |
| Clarus Therapeutics INC. | $37.42 | 2021 | |
| Halozyme INC | $30.04 | 2023 | |
| 180 Medical, INC. | $30.01 | 2019 | |
| Urovant Sciences INC | $29.78 | 2022 | |
| Abbvie INC. | $24.06 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $17.97 | 2019 | |
| Blue Earth Diagnostics | $16.19 | 2019 | |
| Travere Therapeutics, INC. | $14.50 | 2021 | |
| Accord Healthcare, INC. | $13.84 | 2025 | |
| Allergan, INC. | $13.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.